OQROGet OQRO Pro
Insider trade

Alx Oncology (ALXO)CEO sold ~$1.5K

Jason Lettmann, CEO at Alx Oncology, sold ~$1.5K of Alx Oncology shares.

~$1.5K
Approx. value · 2,382 sh @ $0.6404
213K
Holds after · shares reported
Traded
Aug 15, 2025
Filed
Aug 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 30, 2025InsiderOfficer sold ~$659 of ALXO shares in the open market
  2. Jul 7, 2025InsiderOfficer sold ~$905 of ALXO shares in the open market
  3. Aug 15, 2025 · this disclosureInsiderCEO sold ~$1.5K of ALXO shares in the open market

What came next

  1. Aug 15, 2025InsiderOfficer sold ~$391 of ALXO shares in the open market
  2. Aug 18, 2025InsiderCFO purchased ~$58K of ALXO shares in the open market
  3. Sep 11, 2025Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On September 11, 2025, Barbara Klencke, M.D. provided notice that she would resign as a member of the Board of Directors (the “Board”) of ALX Oncology Holdings Inc. (the “Company”) and all committees thereof effective September 17, 2025, in connection with the managerial changes referenced in Item 8.01 below.”
  4. Sep 16, 2025InsiderCEO purchased ~$22K of ALXO shares in the open market
  5. Sep 17, 2025InsiderCEO purchased ~$77K of ALXO shares in the open market
  6. Nov 7, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alx Oncology

For Alx Oncology, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALXO page.

Other recent filings by Jason Lettmann, CHIEF EXECUTIVE OFFICER

The full history of Jason Lettmann, CHIEF EXECUTIVE OFFICER is on the profile page.

How this filing works

Other disclosures at Alx Oncology

Everything OQRO holds on this company is on its ALXO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data